Supernus Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $3.43 billion, with shareholders equity totaling $-60.00 million.
The company employs approximately 563 people and operates in the Health sector, within the Pharmaceutical Products industry.
Over the past 12 months, Supernus Pharmaceuticals Inc. reported $1.37 billion in revenue, generating net income of $451.00 million.
Key financial metrics include a P/E ratio of 7.61, a price-to-book (P/B) ratio of -57.19, and a trailing twelve-month dividend yield of 27.96%.
The company trades under the ticker SUPN.